MedPath

Examination of elobixibat's constipation restoration effect on chronic constipation patients-Retrospective observational research

Not Applicable
Conditions
Chronic constipation
Registration Number
JPRN-UMIN000043911
Lead Sponsor
ishi-Shinjyuku Kisaragi Clinic.
Brief Summary

The percentage of patients having defecation desire was 27.5% before the start of treatment, 76.3% at Week 2 (p<0.001), 97.0% at Week 6 (p<0.001), and 100% at Week 10.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
80
Inclusion Criteria

Not provided

Exclusion Criteria

(1) Patients with a history of hypersensitivity to elobixibat (2) Patients with confirmed or suspected bowel obstruction due to a tumor or hernia (3) Patients with suspected constipation due to organic disease (4) Patients who participated in a clinical trial or interventional study during the study period (5) Patients who have been determined by a physician to be inappropriate to administer elobixibat

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath